A Study of the Safety and Efficacy of Venetoclax in Japanese Participants With Relapsed and Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Leukemia)

Study Identifier
P19-830
CT.gov Identifier
NCT04198415
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Results Available

Scientific Result Summary
Available Language(s): English
Download document(s)

Study Details

Medical Condition
  • Cancer - Other
  • Blood Cancer - Chronic Lymphocytic Leukemia (CLL)
  • Blood Cancer - Leukemia (Other)
    • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    N/A
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    -Prescribed and treated with venetoclax
    Exclusion Criteria:
    None

    Protocol Summary

    This study will collect real-world safety and efficacy data from Japanese relapse/refractory chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL) participants treated with venetoclax.

    Study Locations

    Location
    Status
    Location
    Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital /ID# 239524
    Nagoya, Aichi-ken, Japan, 466-8650
    Status
    Not applicable
    Location
    Nagoya University Hospital /ID# 225300
    Nagoya, Aichi-ken, Japan, 4668560
    Status
    Not applicable
    Location
    Nagoya City University Hospital /ID# 240820
    Nagoya, Aichi-ken, Japan, 467-8602
    Status
    Not applicable
    Location
    Toyohashi Municipal Hospital /ID# 227433
    Toyohashi, Aichi-ken, Japan, 441-8570
    Status
    Not applicable
    Location
    Akita University Hospital /ID# 228510
    Akita, Akita, Japan, 010-8543
    Status
    Not applicable
    Location
    Chiba Aoba Municipal Hospital /ID# 224486
    Chiba, Chiba, Japan, 260-0852
    Status
    Not applicable
    Showing {first} - {last} of {total} Results